Եվրոպական Միություն - ֆիններեն - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - karsinooma, squamous cell - antineoplastiset aineet - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Եվրոպական Միություն - ֆիններեն - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

intervet international b.v. - buserelin acetate - injektioneste, liuos - 4 mikrog/ml - busereliini

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

fresenius kabi ab - magnesium chloride hexahydrate, glucose monohydrate, calcium chloride dihydrate, potassium chloride, sodium acetate trihydrate, sodium chloride - infuusioneste, liuos - elektrolyytit ja hiilihydraatit

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

abbvie oy - prednisolone acetate - silmätipat, suspensio - 10 mg/ml - prednisoloni

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

santen oy - pilocarpine hydrochloride, timolol maleate - silmätipat, liuos - timololi

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

santen oy - pilocarpine hydrochloride, timolol maleate - silmätipat, liuos - timololi

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

piramal critical care b.v. - sufentanil citrate - injektioneste, liuos - 5 mikrog/ml - sufentaniili

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

piramal critical care b.v. - sufentanil citrate - injektioneste, liuos - 50 mikrog/ml - sufentaniili

Ֆինլանդիա - ֆիններեն - Fimea (Suomen lääkevirasto)

santen oy - timololi maleas,pilocarpini hydrochloridum - silmätipat, liuos, kerta-annospipetti - timololi, yhdistelmävalmisteet